How should I work up and manage an adult male with gynecomastia and loss of libido?

Workup and Management of Gynecomastia with Loss of Libido

Begin by measuring morning total testosterone, luteinizing hormone (LH), prolactin, and estradiol levels to determine if testosterone deficiency is present and to identify the underlying etiology. 1, 2

Initial Clinical Assessment

History and Physical Examination

• Document specific symptoms: severity of erectile dysfunction, sexual desire level, intercourse frequency, orgasm difficulties, and ejaculatory function, as gynecomastia correlates with multiple sexual complaints 3
• Identify causative factors: 1, 2
  • Medications (anticonvulsants, estrogens, anabolic steroids, glucocorticoids)
  • Substance use (cannabis abuse is specifically associated with gynecomastia) 3
  • Chronic conditions: liver disease, kidney disease, thyroid disorders, obesity/metabolic syndrome 1, 4
  • History of testicular disease, delayed puberty, or surgical history 3
• Physical examination: measure BMI and waist circumference, assess testicular volume (gynecomastia associates with smaller testis volume), evaluate breast tissue bilaterally to exclude malignancy 1, 3, 5

Laboratory Workup Algorithm

First-Line Testing

1. Morning total testosterone (repeat if low to confirm) 1, 2
2. Serum LH levels to differentiate primary vs. secondary hypogonadism 2
3. Serum estradiol (mandatory in patients presenting with gynecomastia before any testosterone therapy) 2
4. Serum prolactin if testosterone is low with low/normal LH 2

Interpretation and Additional Testing

• If prolactin is elevated: repeat measurement; if persistently elevated, refer to endocrinology and obtain pituitary MRI to evaluate for prolactinoma 2
• If total testosterone <150 ng/dL with low/normal LH: obtain pituitary MRI regardless of prolactin level to exclude non-secreting adenomas 2
• If estradiol is elevated: refer to endocrinology for further evaluation 2
• If fertility is a concern: measure FSH, perform testicular examination, and consider semen analysis 2
• Additional tests as indicated: TSH, liver function tests, kidney function tests, hemoglobin, SHBG (particularly if obesity, metabolic syndrome, or medications that alter SHBG are present) 1, 2

Management Strategy

Address Underlying Causes First

• Eliminate interfering medications/substances when possible 1
• Treat metabolic conditions: weight loss through low-calorie diets can reverse obesity-associated secondary hypogonadism and improve testosterone levels 1
• Manage chronic diseases: optimize treatment of liver disease, thyroid disorders, or other systemic conditions 4, 5

Testosterone Replacement Therapy

If hypogonadism is confirmed (low testosterone with consistent symptoms), initiate testosterone therapy after excluding contraindications and assessing cardiovascular risk factors. 1, 2

• Pre-treatment assessment: measure hemoglobin and assess for cardiovascular disease risk factors (dyslipidemia, hypertension, diabetes, smoking) 2
• Fertility counseling: testosterone therapy suppresses spermatogenesis; patients desiring fertility should consider selective estrogen receptor modulators instead 2
• Transdermal testosterone gel (50 mg/day) is safe and well-tolerated, particularly in patients with liver disease, as it avoids hepatic first-pass metabolism 4
• Expected outcomes: testosterone therapy improves muscle strength, ameliorates gynecomastia, and enhances sexual function 4

Gynecomastia-Specific Management

• Observation: appropriate if mild and recent onset, as breast symptoms sometimes resolve spontaneously 2
• Pharmacotherapy: tamoxifen is an effective option for persistent symptomatic gynecomastia 6
• Surgical correction: indicated for high-grade gynecomastia causing significant psychological distress; surgery can improve erectile function scores (IIEF improved from 17.8 to 23.5 post-operatively) 7

Important Caveats

• Only 33.3% of men with gynecomastia are actually hypogonadal, so testosterone deficiency must be biochemically confirmed before treatment 3
• Avoid testosterone testing during acute illness, as results will be unreliable 1
• Unilateral gynecomastia requires exclusion of male breast cancer through appropriate imaging 5
• Gynecomastia may persist despite testosterone normalization, as the breast tissue changes can be irreversible once established 8, 4
• Monitor for worsening gynecomastia on testosterone therapy: while estradiol levels may increase with treatment, symptomatic progression is uncommon and often self-limited 2